A sad addition

Abdullaeva N.M.

Абдуллаева Н.М.

ФГБОУ ДПО РМАНПО Минздрава России

Грустное дополнение

Авторы:

Абдуллаева Н.М.

Подробнее об авторах

Журнал: Non nocere. Новый терапевтический журнал. 2025;(10): 28‑32

Прочитано: 203 раза

Связаться с автором

Оглавление

Как цитировать:

Абдуллаева Н.М. Грустное дополнение. Non nocere. Новый терапевтический журнал. 2025;(10):28‑32.
Abdullaeva NM. A sad addition. Non Nocere. New Therapeutic Journal. 2025;(10):28‑32. (In Russ.)

Использование инфографики авторами научных работ

Литература / References:

Kanner RE, Morris AH. Clinical and psychological findings of patients with chronic obstructive pulmonary disease. Annals of Internal Medicine. 1976;85(4):447-452.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Prevention, Diagnosis and Management of COPD: 2023 Report (Date of Access: 14.09.2025). https://goldcopd.org/2023-gold-report-2/
Qin P, Hawton K, Mortensen PB, Webb R. Combined effects of physical illness and comorbid psychiatric disorder on risk of suicide in a national population study. Br J Psychiatry. 2014 Jun;204(6):430-435. https://doi.org/10.1192/bjp.bp.113.128785
Dalal AA, et al. Impact of depression on hospitalizations and emergency department use for patients with asthma and chronic obstructive pulmonary disease. Am J Manag Care. 2011;17(8): e298-e306.
Lu Y, et al. The impact of depression and anxiety on mortality in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Affect Disord. 2017;210:188-196.
Nemeroff CB, Vale WW. The neurobiology of depression: inroads to treatment and new drug discovery. Journal of Clinical Psychiatry. 2005;66: Suppl 7:5-13.
van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999 Aug;54(8):688-692. https://doi.org/10.1136/thx.54.8.688
Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013 Sep;144(3):766-777. https://doi.org/10.1378/chest.12-1911
Zhang MWB, et al. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies. Respirology. 2021;26(9): 817-833.
Dantzer R. Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa. Physiol Rev. 2018 Jan 1;98(1):477-504. https://doi.org/10.1152/physrev.00039.2016
Schmaal L, Hibar DP, Sämann PG, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry. 2017 Jun;22(6):900-909. https://doi.org/10.1038/mp.2016.60
Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016 Jan;16(1):22-34. https://doi.org/10.1038/nri.2015.5
Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest. 2011 Sep;140(3):618-625. https://doi.org/10.1378/chest.10-3257
Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010 Dec;25(12):1209-1221. https://doi.org/10.1002/gps.2463
Alexopoulos GS. Depression in the elderly. Lancet. 2005 Jun 4-10;365(9475):1961-1970. https://doi.org/10.1016/S0140-6736(05)66665-2
Iyer AS, Bhatt SP, Garner JJ, et al. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 Feb;13(2):197-203. https://doi.org/10.1513/AnnalsATS.201507-439OC
De Voogd JN, et al. Depressive symptoms as a covariate of health outcomes in patients with COPD. Respir Med. 2010;104(9):1403-1409
Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol. 2015 Jul;30(4):183-192. https://doi.org/10.1097/YIC.0000000000000078
McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015 Feb 23;2015(2): CD003793. https://doi.org/10.1002/14651858.CD003793.pub3
Pollok J, van Agteren JE, Esterman AJ, Carson-Chahhoud KV. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019 Mar 6;3(3):CD012347. https://doi.org/10.1002/14651858.CD012347.pub2
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Prevention, Diagnosis and Management of COPD: 2024 Report (Date of Access: 07.09.2025). https://goldcopd.org/2024-gold-report/
Martinez FJ, Calverley PM, Goehring UM, Brose M, Fabbri LM, Rabe KF. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. Lancet. 2015 Mar 7;385(9971):857-866. https://doi.org/10.1016/S0140-6736(14)62410-7
Blauvelt A, de Bruin-Weller M, Gooderham M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017 Jun 10;389(10086):2287-2303. https://doi.org/10.1016/S0140-6736(17)31191-1